ni falacia de autoridad ni pollas en vinagre no puedes ser mas estúpido
el primero del documento para empezar
Curriculum VitaePERSONAL INFORMATION
Jose Antonio Navarro AlonsoWORK EXPERIENCEMarch 1982- Present Retired. hONORARY cONSULTANT. MINISTRY OF HEALTH. SPAINRetired (Spain)Planification, implementation and assessement of the VPD programmeEDUCATION AND TRAININGMarch 1977-September 1982 Medical degree. Speciality in PediatricsHospital La Paz (Spain)ADDITIONAL INFORMATIONExpertise Immunization Programmes: Logistics, epidemiology VPD, asessement new vaccines introduction,Nominated expert for COVID-19 vaccines. European Commision.Publications PUBLICATIONS. Dobutamine in pediatric cardiovascular surgery. Rev Esp Pediatr 1985;41:361-368. The smoking habit on child health. The child as a passive smoker. An Esp Pediatr 1987;26:60-64. Evaluation of results from school health examinations in Murcia, 1986/1987. Aten Primaria1989;6:406-409. Tubercular infection in first-year basic education students in the Murcia Region (1985-1992). AtenPrimaria 1993;12:573-576. Fluoride use in oral health. Monografias Sanitarias 3. Region de Murcia. 1989. ISBN:84-505-8710-7. Child Care Programme. Region de Murcia 1992. ISBN: 84-87686-27-3. Immunization handbook. Monografias Sanitarias 18. Region de Murcia 1993. ISBN: 84-87686-40-0. Immunization Programme against Hepatitis B. Monografias Sanitarias 19. Region de Murcia 1994.ISBN: 84-87686-45-1. Immunization Programme against Hepatitis B. Second edition. Monografias Sanitarias 22. Regionde Murcia 1995. ISBN: 84-87686-71-0. Immunization Programme against Hepatitis B. Third edition. Monografias Sanitarias 23. Region deMurcia 1998. ISBN: 84-87686-77-X. Evaluation of the school health programme of Murcia. An Esp Pediatr 1991;35:41-44. The introduction of the child health booklet in the Murcia Region. Aten Primaria 1994;14:596-601. New vaccines in medicine. prospects. Aten Primaria 1997;19:431-440. Varicella. Universal or selective vaccination?. Aten Primaria 1998;22:457-462. Influenza epidemiologic surveillance 98/99. Boletin Epidemiologico de Murcia 1998;20:37-40. Influenza epidemiologic surveillance 99/00. Boletin Epidemiologico de Murcia 1999;20:45-49. Prospects in vaccination against meningococcus B. Vacunas. investigacion y practica2000;1:10-13. Evaluation of dental health on school population from Murcia. Archivos de Odontoestomatologia1999;15:536-544. Seroconversion and duration of immunity after vaccination against group C meningococcalinfection in young children. Vaccine 2000;18:2656-2600. II Survey on dental health in school population from Murcia. Informes Sanitarios 26. Region deMurcia 2000. ISBN: 84-95393-09-3. Murcia´s Immunisation Registry. Vacunas. Investigacion y practica 2000;1:137-14026/10/2021 European Medicines Agency Page 1/5. Serogroup C Neisseria meningitidis vaccination. An Esp Pediatr 2000;53:608. Vaccination schedules and coverages in European countries, Vacunas. Investigacion y Practica2000;1.188-194. Analysis of factors influencing vaccine uptake: perspectives from Spain. Vaccine 2001;20:S13-S15. Cost-effectiveness of immunisation against serogroup C Neisseria meningitides with conjugatevaccine. Vacunas:investigacion y practica 2001;2:91-95. Immigration and immuno-preventable diseases. Vacunas. Investigacion y practica 2001;2:110-117. Attitudes, knowledges, beliefs, sources of information and satisfaction level with the VaccinationProgramme of Murcia. Vacunas. Investigacion y practica 2001;2:142-149. Vaccinology at the beggining of the XXI century (First part). Atencion Primaria 2002;29:569-574. Vaccinology at the beggining of the XXI century (Second part). Atencion Primaria 2002;30:130-133. Pneumococcal invasive disease in children of the Murcia´s Region. Gaceta Sanitaria2002;16:385-391. Prospects in immuno-preventable diseases eradication. Medicina Clinica (Barc.) 2002;15:574-579. Combination vaccines: a new era. Vacunas. Investigacion y practica 2002; 3: S1-S5. Immunisation against serogroup B Neisseria meningitidis. Enfermedades Infecciosas yMicrobiologia Clinica 2003;21:506-512. Editorial. Haemophilus influenzae type b. ¿Antibody titles, immunologic memory or both. AnalesEspanoles de Pediatria 2003;59:429-430. Quality of the computerised immunisation Registry of Murcia. Vacunas 2004;5:83-86. Reasons to vaccinate. Aten Primaria 2004;34 (Extraordin 1):69-71. The vaccination schedule. JANO 2005;68:1740-1744. Vaccine´s introduction into ordinary calendars. Public Health perpective. Pediatria AtencionPrimaria 2005;7:S19-S27. Poliovirus: Can we reach elimination? Vacunas 2005;6:138-144. Immunization against serogroup C Neisseria meningitidis with conjugate vaccines: 7-yearsexperience. Pediatria Atencion Primaria 2006;8:65-86. Olin P, Dagan R, Mau J, Navarro Alonso JA on behalf of the Scientific Panel on Vaccines andImmunisation. Use of pneumococcal polysaccharide vaccine for subjects over 65 years of ageduring an inter-pandemic period. Technical Report. European Centre for Disease Control.Stockholm, January 2007. Olin P, Dagan R, Mau J, Navarro Alonso JA on behalf of the Scientific Panel on Vaccines andImmunisation. Infant and children seasonal immunisation against influenza on a routine basis duringinter-pandemic period. Technical Report. European Centre for Disease Control. Stockholm, January2007. Navarro Alonso JA, Bernal Gonzalez PJ, Perez Martin JJ. Uncertainties regarding humanpapillomavirus vaccine introduction. Med Clin (Barc) 2007;129:55-60. Barricarte A, Castilla J, Gil A, Torroba L, Navarro Alonso JA, Irisarri F, Arriazu M. Effectiveness ofthe seven valent pneumococcal conjugate vaccine: a population-based case-control study. ClinInfect Dis 2007;44: 1436-1441. Barricarte A, Castilla J, Navarro-Alonso JA. Reply to Bernaola et al and to Moore et al. Clin InfectDis 2007;45:1242-1243. Navarro Alonso JA. Meningococcal vaccines. Enf Infecc Microbiol Clin 2007;25 Suppl 4: 20-28. Navarro Alonso JA, Bernal Gonzalez PJ, Perez Martin JJ. Reply to Martinon. Med Clin (Barc)2008;130:478-479. Granstrom M, Molnar S, Navarro-Alonso JA on behalf of the Scientific Panel on childhoodimmunization schedule. Technical Report. European Centre for Disease Control. Stockholm,February 2009. Navarro Alonso JA, Bernal Gonzalez PJ, Perez Martin JJ. Pandemic vaccines Challenges. Revistade Administracion Sanitaria 2009;7:443-457. Bernal Gonzalez P, Navarro Alonso J, Perez Martin J. Computerised vaccination register for theMurcia Region, Spain, 1991 to 2011. Euro Surveill. 2012;17(16)
ii=20150REPORTS. Assessement of the pertussis vaccination programme in Spain. January 2013. Spanish Ministry ofHealth.26/10/2021 European Medicines Agency Page 2/5http://www.msc.es/profesionales/saludPublica/prevPromocion/vacunaciones/docs/TosFerina.pdf. Assessement of the MenC vacccination programme in Spain. January 2013. Spanish Ministry ofHealthhttp://www.msc.es/profesionales/saludPublica/prevPromocion/vacunaciones/docs/MenC.pdf. Assessement of the HPV vaccination programme in Spain. January 2013. Spanish Ministry ofHealthhttp://www.msc.es/profesionales/saludPublica/prevPromocion/vacunaciones/docs/PapilomaVPH.pdf. Vaccine against invasive meningococcal disease by serogroup B and its use in Public Health. June2013. Spanish Ministry of Healthhttp://www.msssi.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/docs/MenB.pdf. Recommended use of Bexsero in special situations. Spanish Ministry of Health. March 2014.
http://www.msssi.gob.es/profesionale...s.pdfVaricella. Vaccination in risk groups. 2015.
http://www.msssi.gob.es/profesionale...dfPneumococcal vaccination in high-risk groups 2015.
http://www.msssi.gob.es/profesionale...posriesgo.pdfA new vaccination Schedule for Spain. 2016.
http://www.msssi.gob.es/profesionale...cunacion.pdfTd vaccine recommendations in shortages, 2017.
http://www.msssi.gob.es/ciudadanos/p...dfImmunization in health care workers, 2017.
http://www.msssi.gob.es/profesionale...s.pdfHepatitis A vaccination in high-risk groups. 2017.
http://www.msssi.gob.es/profesionale...A.pdfHepatitis B vaccination in shortages. 2017.
http://www.msssi.gob.es/profesionale...pdfVaccination in all ages high-risk people, 2018https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/VacGruposRiesgo/Vac_GruposRiesgo_todasEdades.htmBOOK CHAPTERSFermin Garcia Rodriguez, Jose A. Navarro Alonso, Virtudes Gallardo Garcia. Vaccinations inchidren with chronic diseases. In: Atencion integral a la infancia con patologia cronica. IgnacioGomez de los Terreros, Fermin Garcia Rodriguez, Montserrat Gomez de Terreros, editores. 1ªedicion. Editorial Alhulia, Granada, 2002:435-455. Jose A. Navarro Alonso. Immigration and immuno-preventable diseases. In: Salleras Ll, editor.Vacunaciones preventivas. Principios y aplicaciones. 2ª edicion. Barcelona: Masson; 2003. p.889-907. Jose A. Navarro Alonso, Pedro J. Bernal Gonzalez, Jose L. de la Torre. General recommendationson vaccination. In: Salleras Ll, editor. Vacunaciones preventivas. Principios y aplicaciones. 2ªedicion. Barcelona: Masson; 2003. p.731-741. Ll Salleras, Dominguez A, Navarro JA. Pneumococcal conjugate vaccine. In: Salleras Ll, editor.Vacunaciones preventivas. Principios y aplicaciones. 2ª edicion. Barcelona: Masson; 2003.p.399-421. Navarro Alonso JA. Meningococcal disease vaccines. In: IX Jornadas Internacionales sobreActualizacion en Vacunas. De Juanes ed. Febrero. 2.001 p:25-35. Navarro Alonso JA. Serogroup B Neisseria meningitidis vaccination. In: Vacunas 2001. Moraga F yCamping M eds. Prous Science, Barcelona. 2002: 27-37. Navarro Alonso JA. Vaccination schedules in immigrant population. The Murcia´s RegionProgramme. In: Vacunas 2003. Campins M y Moraga F eds. Prous Science, Barcelona 2003:26/10/2021 European Medicines Agency Page 3/5175-183. Navarro Alonso JA. Adult immigrant vaccination schedule. In: Vacunaciones en el adulto. Guia yrecomendaciones. de Juanes Pardo ed. 2ª edicion, Barcelona 2003: 277-285. Navarro Alonso JA. Inactivated poliomielitis vaccine vs attenuated vaccine. In: Actualizacion envacunas, 2004. de Juanes Pardo ed. Madrid 2004: 37-49. Navarro Alonso JA. Mendez Diaz M. Recommended vaccination schedules in infancy. In:Vacunaciones en el nino. De la teoria a la practica. Aristegui ed. Ciclos editorial SL. Bilbao2004:242-263. Navarro Alonso JA. Recommended vaccination schedules in adolescents. In: Vacunaciones en elnino. De la teoria a la practica. Aristegui ed. Ciclos editorial SL. Bilbao 2004:272-281. Navarro Alonso JA. Meningococcus. In: Vacunaciones en el nino. De la teoria a la practica.Aristegui ed. Ciclos editorial SL. Bilbao 2004:483-511. Navarro Alonso JA. Strategies to increase the vaccination coverages. In: Vacunaciones en el nino.De la teoria a la practica. Aristegui ed. Ciclos editorial SL. Bilbao 2004:797-808. Bernal Gonzalez PJ, Navarro Alonso JA. Immunisation registries. In: Vacunaciones en el nino. Dela teoria a la practica. Aristegui ed. Ciclos editorial SL. Bilbao 2004:165-181. Navarro Alonso JA. Hexavalent vaccines and SIDS. In: Vacunas 2004. Campins M y Moraga Feds. Prous Science, Barcelona 2004: 153-161. Navarro Alonso JA. Bernal Gonzalez P J, Perez Martin J J. Immigration and immuno-preventablediseases. En: La salud del inmigrante. Lopez Velez R editor, Madrid 2006:38-67. Navarro Alonso JA. Vaccination policies at the EU. En: Vacunas 2007. Campins M y Moraga F.GlaxoSmithKline eds, Madrid 2008: 3-11. Navarro Alonso JA. Q&A in Vaccinology. En: Vacunas 2009. Campins M y Moraga F. Lenoirediciones, Barcelona 2009: 209-233. Navarro Alonso JA. Q&A about varicela and zoster vaccines. Magda Campins Ed. Marge MedicaBooks, 2011. Navarro Alonso JA, Bernal Gonzalez PJ. Rabies. Vacunas en Pediatria. Manual de la AEP 2012.Exlibris Eds. 2012. Perez Martin, J. Navarro Alonso JA. Meningococcus. Vacunas en Pediatria. Manual de la AEP2012. Exlibris Eds. 2012. Navarro Alonso JA. AEFI´s surveillance. Campins Marti M, Moraga Llop F, editores. Vacunas2012. Barcelona: Graficas Campas;2012. Perez Martin JJ, Sanchez Manresa S, Bernal Gonzalez PJ, Navarro-Alonso JA. Evaluacion delpilotaje de un programa de captacion de ninos no vacunados frente a vacuna triple virica. BoletinEpidemiologico de Murcia 2013;33:97-102. Limia Sanchez A, Navarro Alonso JA, Salmeron Sanchez F. Immunisation against meningococcusB: the case of Spain. The Lancet 2014;383:217-218. Recommended use of Bexsero in special situations. Spanish Ministry of Health. March 2014.
http://www.msssi.gob.es/profesionale...Especiales.pdf. Navarro Alonso JA, Perez Martin JJ. Vacunas antimeningococicas polisacaridas simples y deproteinas de membrana externa. En: La enfermedad meningococica. Pasado, presente y futuro.Moraga-Llop F ed. Graficas Montseny;2013. Perez Martin JJ, Navarro Alonso JA. Evolucion de las enfermedades infecciosas tras lavacunacion. En: Vacunas. Algo mas que el calendario vacunal. Ines Hidalgo y Monton Alvarez eds.2ª edicion. 2014. Navarro Alonso JA. Vacunacion frente a Streptococcus agalactiae. Vacunas 2015. Campins Martiy Moraga Llop editores. Madrid: Undergraf;2015Limia Sanchez A, Navarro Alonso JA, Salmeron Sanchez F. Immunisation against meningococcusB: the case of Spain. The Lancet 2014;383:217-218Limia Sanchez A, Andreu Maria del Mar, de Viarce Torres M, Navarro Alonso JA. Nuevo calendariode vacunacion para Espana, 2016 (parte 1). Rev Esp Salud Publica 2016;90:e1-e9Navarro Alonso JA, Taboada Rodriguez JA, Limia Sanchez A. Nuevo calendario de vacunacionpara Espana, 2016 (parte 2). Rev Esp Salud Publica 2016;90:e1-e9Perez-Martin J, Navarro-Alonso JA, Cayuela-Fuentes J, Bernal-Gonzalez P (2016) VaccinationProgram against HPV in Women with Exci¬sional Treatment Due to Preneoplasic Cervical Lesionsin the Region of Murcia: Results of the First Year. Clin Res Infect Dis 3(3): 103126/10/2021 European Medicines Agency Page 4/5Urbiztondo L, Perez-Martin J, Borras-Lopez E, Navarro Alonso JA. Immunization recommendationsagainst hepatitis A in Spain: Effectiveness of immunization in MSM and selection of antigenicvariants. EBioMedicine.2019; 45: 19-20ProjectsMemberships SCIENTIFIC COMMITTEES. National Advisory Committee on Immunizations. Spanish Ministry of Health, 1993-2013. Secretary, Regional Advisory Committee on Immunizations, 1998-2007. Member, Editorial Council "Vacunas. Investigacion y practica", 2000-2013. President of the Scientific Committee, I Congress of the Spanish Association for Vaccinology.Cadiz, 15-17 november 2001. Member, Scientific Committee of the 2nd Congress of the Spanish Association for Vaccinology.Las Palmas de Gran Canaria. 12-15 November 2003.. Member, Scientific Committee of the 23nd Annual Meeting of the European Society for PaediatricInfectious Diseases". Valencia, 18-20 mayo 2005. Member, Scientific Committee of the 3nd Congress of the Spanish Association for Vaccinology.Madrid. 10-12 November 2005. Head. Influenza Pandemic Preparedness. Region of Murcia. Spain, 2004-2013. Member. Vaccines and Immunization Panel. European Centre for Disease Prevention and Control.Stockholm (Sweden) (1996/1999). Member European Vaccination Advisory Group (EVAG. ECDC). Expert. Spanish Medicines Agency.
Falacia de idiotez que te gastas tu so bobooooooooooooooooooooooooooooooooooooooooooooooo